Biotech leads new wave of innovation funding across strategic sectors. Recent funding rounds highlight strong investment in biotech, industrial tech, agriculture, and deep tech. Brenus Pharma raised €11 million to advance cancer immunotherapy, while Pelico scales AI-driven manufacturing optimization. Aptimiz improves farm management, Remedy Metals targets rare earth refining, and Muodim develops non-invasive imaging technologies for industrial and infrastructure applications globally across diverse critical sectors. 1 hour ago August 6, 2026 Several European startups have recently secured funding to accelerate innovation across biotech, industrial software, agriculture, and advanced materials - highlighting sustained investor interest in high-impact, technology-driven sectors. Biotech and industrial innovation attract strategic capital. The biotech company Brenus Pharma stands out with an €11 million extension to its Series A round, including €3.5 million in debt, bringing its total funding to €38 million since inception. Based in Lyon, the company is developing an off-the-shelf in vivo immunotherapy platform designed to target so-called "cold" tumors, which represent approximately 85% of solid cancers and remain largely unresponsive to existing immunotherapies. Its lead candidate, STC-1010, is currently in Phase I trials for metastatic colorectal cancer (MSS) and has received FDA approval for its Investigational New Drug (IND) application. The newly secured funding by the biotech company will support the completion of this trial phase and enable further pipeline development. The round also marks the entry of new institutional investors, including Sambrinvest and Korea Omega Investment Corp, the latter becoming Brenus Pharma's first investor from the Asia-Pacific region. In the industrial technology space, Pelico has raised an additional funding round from AE Ventures, although the amount remains undisclosed. The company develops an AI-powered production orchestration platform that helps manufacturers optimize operations, anticipate supply chain disruptions, and improve efficiency. Positioned within the rapidly growing market for real-time shop floor management tools, Pelico addresses increasing industrial complexity and time constraints faced by manufacturers. Emerging solutions in agriculture, materials, and imaging. Other startups are tackling structural challenges in agriculture and resource management. Aptimiz has secured €1.4 million in Series A funding to expand its agricultural management platform. The solution leverages real-time data analysis to automate the coordination of staff, machinery, and field operations. This approach responds to mounting pressures on agricultural profitability and persistent labor shortages. The round was led by Demeter, alongside multiple co-investors. Meanwhile, Remedy Metals has raised €1 million in its first funding round, including €500,000 through convertible bonds from Bpifrance. Founded in 2024, the company is developing an electrochemical process for refining rare earth elements - materials critical for electric motors, wind turbines, and digital technologies. This positions the company within a strategic segment of the energy transition, where supply chain resilience is increasingly important. Finally, the biotech company Muodim has secured €700,000 in seed funding to advance its muon tomography technology. This imaging method uses naturally occurring cosmic particles to generate detailed 2D and 3D views of subsurface structures without causing damage. Applications range from infrastructure monitoring, such as dams, to industrial inspections. The round is led by BRGM Invest and Iris Instruments, both key players in geoscience and measurement technologies. Together, these funding rounds reflect a broader trend: capital is flowing toward solutions that combine deep technology, operational efficiency, and strategic relevance across industries like biotech, facing environmental, industrial, and structural challenges. DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review its disclaimer for more information. This article may include forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures. First published in Finyear. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail. Although Born2Invest made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, Born2Invest encourage you to contact Born2Invest. Eva Wesley is an experienced journalist, market trader, and financial executive. Driven by excellence and a passion to connect with people, she takes pride in writing think pieces that help people decide what to do with their investments. A blockchain enthusiast, she also engages in cryptocurrency trading. Her latest travels have also opened her eyes to other exciting markets, such as aerospace, cannabis, healthcare, and telcos.

Pelico, a manufacturing orchestration platform, has secured a strategic investment from AE Ventures, the venture arm of AE Industrial Partners, a private investment firm focused on aerospace and defence. Financial terms were not disclosed. The investment connects Pelico to AE Industrial's portfolio companies and network, accelerating its North American expansion. Pelico's AI-powered platform helps factory teams anticipate disruptions and coordinate operations across complex supply chains. The company's clients include Boeing, Safran and Daikin. Manufacturers deploying Pelico report an average 40% reduction in parts shortages, 15% improvement in on-time delivery and 40% reduction in cycle times. Boeing Global Services is using Pelico to connect planning, supply and execution teams in maintenance and repair operations. Founded in Paris in 2019, Pelico serves global manufacturers across aerospace and industrial sectors.